Company:  MACROGENICS INC (MGNX)
Form Type:  S-8
Filing Date:  3/14/2019 
CIK:  0001125345 
Address:  9704 MEDICAL CENTER DRIVE 
City, State, Zip:  Rockville, Maryland 20850 
Telephone:  301-251-5172 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$14.28  
Change: 
-0.84 (-5.56%)  
Trade Time: 
Aug 23  
Market Cap: 
$698.20M
Trade MGNX now with

© 2019  
Description of Business
Except as otherwise indicated herein or as the context otherwise requires, references in this annual report on Form 10-K to "MacroGenics," the "company," "we," "us" and "our" refer to MacroGenics, Inc. and its consolidated subsidiaries. MacroGenics, the MacroGenics logo, DART(R), TRIDENTTM and the phrase "Breakthrough Biologics, Life-Changing Medicines" are our trademarks or registered trademarks. The other trademarks, trade names and service marks appearing in this report are the property of their respective owners. Overview We are a biopharmaceutical company focused on discovering and developing innovative antibody-based therapeutics designed to modulate the human immune response for the treatment of cancer.
Register and access this filing in:     
  FORM S-8
    CALCULATION OF REGISTRATION FEE
    EXPLANATORY NOTE
    PART II
      Item 3. Incorporation of Certain Documents by Reference.
      Item 8. Exhibits.
    SIGNATURES
    INDEX TO EXHIBITS
  EXHIBIT 5.1
  EXHIBIT 23.2
    Consent of Independent Registered Public Accounting Firm